1. Home
  2. SBLK vs PBLS Comparison

SBLK vs PBLS Comparison

Compare SBLK & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Star Bulk Carriers Corp.

SBLK

Star Bulk Carriers Corp.

SELL

Current Price

$27.83

Market Cap

3.4B

ML Signal

SELL

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

HOLD

Current Price

$23.38

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBLK
PBLS
Founded
2006
2015
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.6B
IPO Year
2007
2026

Fundamental Metrics

Financial Performance
Metric
SBLK
PBLS
Price
$27.83
$23.38
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$34.44
★ $41.75
AVG Volume (30 Days)
★ 1.6M
1.2M
Earning Date
11-18-2026
11-17-2026
Dividend Yield
★ 5.00%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.73
N/A
Revenue Next Year
N/A
$222.58
P/E Ratio
$47.06
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.29
$24.80
52 Week High
$32.88
$42.49

Technical Indicators

Market Signals
Indicator
SBLK
PBLS
Relative Strength Index (RSI) 34.97 27.12
Support Level $27.15 N/A
Resistance Level $28.39 $41.72
Average True Range (ATR) 0.73 2.22
MACD -0.27 -0.51
Stochastic Oscillator 4.52 3.88

Price Performance

Historical Comparison
SBLK
PBLS

About SBLK Star Bulk Carriers Corp.

Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. The firm generates the majority of its revenue from Time charters and Voyage charters.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: